Last reviewed · How we verify
Intradermal avotermin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Intradermal avotermin (Intradermal avotermin) — Renovo.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intradermal avotermin TARGET | Intradermal avotermin | Renovo | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intradermal avotermin CI watch — RSS
- Intradermal avotermin CI watch — Atom
- Intradermal avotermin CI watch — JSON
- Intradermal avotermin alone — RSS
Cite this brief
Drug Landscape (2026). Intradermal avotermin — Competitive Intelligence Brief. https://druglandscape.com/ci/intradermal-avotermin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab